ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2022

Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing-Remitting Multiple Sclerosis After Fingolimod Withdrawal.

Fabien Rollot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.